Group 1 - JSR Limited and Best Idea International Limited are transferring shares of Shanghai Mengke Pharmaceutical Co., Ltd., with JSR's shareholding decreasing from 5.88% to 4.70% after the transfer [1][3] - The total number of shares being transferred is 18,049,000 at a price of 6.57 CNY per share, which is 85% of the average trading price over the last 20 days [6][8] - Best Idea International Limited's shareholding will decrease from 10.49% to 8.91%, bringing its ownership below 10% [5][3] Group 2 - The transfer process involved sending a subscription invitation to 102 institutional investors, including private equity funds and public fund management companies [7][8] - The final transfer price was confirmed at 6.57 CNY per share, with the transfer process adhering to regulatory requirements [8][9] - The transfer does not result in a change of control for the company, as the major shareholders remain unchanged [8][3]
盟科药业: 上海盟科药业股份有限公司股东询价转让结果报告书暨持股5%以上股东权益变动触及5%和1%整数倍的提示性公告